May Biodegradable and Biocompatible Polymeric Microneedles be Considered as a Vaccine and Drug Delivery System in the COVID-19 Pandemic?

References (8)

1. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427
2. Shaikh S, Bhan N, Rodrigues FC, Dathathri E, De S, Thakur G. Microneedle platform for biomedical applications. In: Shaikh S, Bhan N, Rodrigues FC, Dathathri E, De S, Thakur G, eds. Bioelectronics and Medical Devices. London: Elsevier; 2019:421-441
3. Vora LK, Moffatt K, Tekko IA, Paredes AJ, Volpe-Zanutto F, Mishra D, Peng K, Raj Singh Thakur R, Donnelly RF. Microneedle array systems for long-acting drug delivery. Eur J Pharm Biopharm. 2021;159:44-76
4. Norman JJ, Brown MR, Raviele NA, Prausnitz MR, Felner EI. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2013;14:459-465
5. Maurya A, Nanjappa SH, Honnavar S, Salwa M, Murthy SN. Rapidly dissolving microneedle patches for transdermal iron replenishment therapy. J Pharm Sci. 2018;107:1642-1647
6. Duarah S, Sharma M, Wen J. Recent advances in microneedle-based drug delivery: special emphasis on its use in paediatric population. Eur J Pharm Biopharm. 2019;136:48-69. 7. van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release. 2012;161:645-655
7. Koyani RD. Synthetic polymers for microneedle synthesis: from then to now. J Drug Deliv Sci Technol. 2020:102071. doi: 10.1016/j. jddst.2020.102071
8. Frew PM, Paine MB, Rouphael N, Schamel J, Chung Y, Mulligan MJ, Prausnitz MR. Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity. Vaccine. 2020;38:7175-7181.